Genpact Limited (NYSE:G – Get Free Report) SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Genpact Stock Up 1.1 %
Genpact stock opened at $44.83 on Friday. The stock’s fifty day moving average is $44.45 and its two-hundred day moving average is $39.58. The stock has a market cap of $7.91 billion, a PE ratio of 12.32, a P/E/G ratio of 1.43 and a beta of 1.18. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $47.98. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the stock. Needham & Company LLC increased their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, November 11th. TD Cowen raised their price target on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a research report on Friday, November 8th. Finally, Robert W. Baird increased their price objective on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $42.33.
Hedge Funds Weigh In On Genpact
A number of institutional investors and hedge funds have recently added to or reduced their stakes in G. Jensen Investment Management Inc. increased its position in shares of Genpact by 6.4% during the third quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock worth $7,449,000 after purchasing an additional 11,410 shares in the last quarter. Stifel Financial Corp purchased a new position in Genpact during the 3rd quarter worth approximately $1,197,000. Vanguard Personalized Indexing Management LLC increased its position in Genpact by 53.1% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 49,134 shares of the business services provider’s stock worth $1,580,000 after buying an additional 17,034 shares during the period. Burney Co. lifted its stake in Genpact by 242.8% in the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after buying an additional 92,641 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- What is a Special Dividend?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What is Put Option Volume?
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- 3 Healthcare Dividend Stocks to Buy
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.